Delivery Order SPE2DB20D1004-SPE2DB22FF2M2

Award Date 2/15/22
Potential Completion Date 2/16/22
Potential Value $3.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,677.21 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The award is under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,798.98 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,436.95, is for the delivery of Eliquis 5 mg tablets. This is a delivery order contract with a firm fixed price pricing type and a completion date of November 25, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,243.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The $10,648.27 fixed-price contract has an ultimate completion date of April 7, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,301.44 firm fixed-price delivery order covers the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,153.37 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets and has an ultimate completion date of November 22, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,045.75, is a delivery order placed under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The single-award contract has a ceiling value of $4,287.52 and a period of performance through January 24, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The award, valued at $9,443.98, was made by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of February 27, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., worth up to $999,999,999.00. This IDC serves as the primary...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB22FF2M2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,599.24 Firm Fixed Price Delivery Order is for the supply of Eliquis 5 mg tablets, with a performance period running through February 16, 2022.

The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00 and running through November 2026, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 10:53 AM